Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1998
10/22/1998CA2285335A1 Selective factor xa inhibitors
10/22/1998CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998CA2284525A1 Inhibitors of cholesterol esterase
10/22/1998CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/21/1998EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998EP0872478A2 Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
10/21/1998EP0872465A2 Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl) butane and intermediates thereof
10/21/1998EP0872245A1 Methods for treating vascular disorders with activated Protein C
10/21/1998EP0872244A1 Cosmetic or pharmaceutical composition containing an Andiroba extract
10/21/1998EP0872236A1 Eye drops
10/21/1998EP0872235A1 Therapeutic agents
10/21/1998EP0871883A1 Compounds and methods related to parathyroid hormone-like protein
10/21/1998EP0871748A2 Delivery of biologically active polypeptides
10/21/1998EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998EP0871667A1 G-protein coupled receptor
10/21/1998EP0871664A1 Novel chemokine for mobilizing stem cells
10/21/1998EP0871661A1 Novel protein domain which binds tyrosine phosphorylated proteins
10/21/1998EP0871655A2 Pcna binding substance
10/21/1998EP0871653A1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
10/21/1998EP0871624A1 Antagonists of gonadotropin releasing hormone
10/21/1998EP0871623A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
10/21/1998EP0871622A1 Novel compounds
10/21/1998EP0871615A1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/21/1998EP0871614A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
10/21/1998EP0871611A1 New derivatives of glycylanilides, preparation and therapeutical application
10/21/1998EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions
10/21/1998EP0871487A1 Dendritic cell stimulatory factor
10/21/1998EP0871477A1 Method for obtaining receptor agonist antibodies
10/21/1998EP0871475A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors
10/21/1998EP0871473A1 Pharmaceutical composition containing il-10
10/21/1998EP0871471A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
10/21/1998EP0871467A1 Novel formulation for peptide release
10/21/1998EP0871464A1 Bradykinin analogs as selective thrombin inhibitors
10/21/1998EP0871457A1 Isolated stromal cells and methods of using the same
10/21/1998EP0871456A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/21/1998EP0871446A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye
10/21/1998EP0871445A1 Composition for treating pain
10/21/1998EP0871444A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
10/21/1998EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition
10/21/1998EP0775129B1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists
10/21/1998EP0739351A4 Monomeric diols and phosphate linked oligomers formed therefrom
10/21/1998EP0658199B1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells
10/21/1998EP0651740B1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
10/21/1998CN1196728A Prolylendopeptidase inhibitors
10/21/1998CN1196726A 4,5-diaryl oxazole derivatives
10/21/1998CN1196680A Endothelin receptor antagonists
10/21/1998CN1196678A Di-and trivalent small molecule selecting protein inhibitors
10/21/1998CN1196258A Compounding method and technology for pure natural anti-senile preparation
10/21/1998CN1040330C Anti-bradykinin compound of N-terminal modification and preparation method and composition thereof
10/21/1998CN1040326C Preparation method of imidazopyridine PAF/H1 antagonists
10/21/1998CN1040288C Use of 1,3-dithiole-2-isodipropyl malonate in preparing medicine for accelerating wound healing
10/20/1998US5824782 Immunoconjugates II
10/20/1998US5824702 Antioxidant behavior, prevents molecular changes leading to skin cancer, prevents protooncogene expression and tumorigenesis
10/20/1998US5824696 Medicaments
10/20/1998US5824693 Method for treatment for pulmonary disease
10/20/1998US5824688 HIV protease inhibitors
10/20/1998US5824678 Morpholine derivatives and their use as therapeutic agents
10/20/1998US5824673 Pharmaceutical compositions comprising metal complexes
10/20/1998US5824661 Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism
10/20/1998US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998US5824550 Voltage-gated calcium channel and antisense oligonucleotides thereto
10/20/1998US5824519 A dna sequence comprising a specific binding promoter encoding a ribozyme as antitumor agents, viricides, antiproliferative agents; drug delivery
10/20/1998US5824500 Nucleic acid encoding novel human KDEL receptor
10/20/1998US5824492 Polypeptides having kinase activity, their preparation and use
10/20/1998US5824320 Cosmetic or pharmaceutical compositions containing, as active ingredient, mangiferine or its derivatives, in pure form or in plant extracts
10/20/1998US5824304 Peripheralization of hematopoietic stem cells
10/20/1998US5824303 Dna sequence encoding, proteins and peptides
10/20/1998US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/20/1998US5824297 Administering transforming growth factor beta to cancer patients before chemotherapy; side effect reduction of oraland gastrointestinal mucositis
10/16/1998CA2234789A1 New naphthylpiperazine derivatives
10/15/1998WO1998045711A2 Assay for ligands to tyrosine kinase receptors
10/15/1998WO1998045335A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
10/15/1998WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998WO1998045315A1 Estra-5(10),7-dienes with estrogenic activity
10/15/1998WO1998045309A1 Novel phosphate compounds and their use as medicaments
10/15/1998WO1998045294A1 Compounds
10/15/1998WO1998045293A1 Pyrimido-isoquinoline compounds with anticonvulsive action
10/15/1998WO1998045288A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators
10/15/1998WO1998045285A1 Somatostatin agonists
10/15/1998WO1998045276A2 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
10/15/1998WO1998045275A1 Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity
10/15/1998WO1998045270A1 Pharmacological agents
10/15/1998WO1998045268A1 Nicotinamide derivatives
10/15/1998WO1998045256A1 Hydroxamic acid derivatives
10/15/1998WO1998045242A1 Retinoid activity regulators
10/15/1998WO1998045241A2 Lutein esters having high bioavailability
10/15/1998WO1998044939A1 Anti-peptide antibody against human cytochrome p450 3a4
10/15/1998WO1998044925A1 Calcilytic compounds
10/15/1998WO1998044922A1 Somatostatin agonists
10/15/1998WO1998044921A1 Somatostatin agonists
10/15/1998WO1998044919A1 Use of aminothiolester derivatives in pharmaceutics
10/15/1998WO1998044918A1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
10/15/1998WO1998044893A2 Method and formulation for treating vascular disease
10/15/1998WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998WO1998024806A3 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
10/15/1998CA2287293A1 Somatostatin agonists
10/15/1998CA2286457A1 Estra-5(10),7-dienes with estrogenic activity
1 ... 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 ... 1564